Werner E - Search Results

1

Towards in vitro potency testing of inactivated erysipelas vaccines.

Balks E, Wolf C, Loessner H, Werner E. Balks E, et al. Among authors: werner e. Dev Biol (Basel). 2012;134:37-44. Dev Biol (Basel). 2012. PMID: 22888593

2

Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.

Ebert E, Oppling V, Werner E, Cussler K. Ebert E, et al. Among authors: werner e. FEMS Immunol Med Microbiol. 1999 Jul;24(3):299-311. doi: 10.1111/j.1574-695X.1999.tb01298.x. FEMS Immunol Med Microbiol. 1999. PMID: 10397315 Free article.

3

Development and prevalidation of alternative methods for the potency testing of C. perfringens vaccines.

Ebert E, Öppling V V, Werner E, Cubetaler K. Ebert E, et al. Among authors: werner e. ALTEX. 1998;15(5):59-61. ALTEX. 1998. PMID: 11178544 English.

4

[Progress in the replacement of animal experiments in the quality control of clostridial vaccines].

Cussler K, Borrmann E, Werner E. Cussler K, et al. Among authors: werner e. Dtsch Tierarztl Wochenschr. 2002 Apr;109(4):172-7. Dtsch Tierarztl Wochenschr. 2002. PMID: 11998369 Review. German.

5

Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.

Rosskopf-Streicher U, Volkers P, Noeske K, Werner E. Rosskopf-Streicher U, et al. Among authors: werner e. ALTEX. 2004;21 Suppl 3:65-9. ALTEX. 2004. PMID: 15057410

6

Vaccines for minor species and minor indications: current situation and concepts in Germany--feasible approaches for the future--authorities' view.

Werner E. Werner E. Dev Biol (Basel). 2004;117:165-70. Dev Biol (Basel). 2004. PMID: 15597635

7

Development and validation of a serological potency test for the release of Leptospira vaccines--requirements in the European Union.

Balks E, Gyra H, Kobe B, Cussler K, Werner E. Balks E, et al. Among authors: werner e. Biologicals. 2013 Sep;41(5):325-9. doi: 10.1016/j.biologicals.2013.06.011. Epub 2013 Aug 1. Biologicals. 2013. PMID: 23911253

8

Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of a Salmonella vaccine strain.

Roos K, Werner E, Loessner H. Roos K, et al. Among authors: werner e. Microb Biotechnol. 2015 Jan;8(1):177-87. doi: 10.1111/1751-7915.12187. Epub 2014 Dec 9. Microb Biotechnol. 2015. PMID: 25488129 Free PMC article.

9

An in vitro alternative to the mouse neutralisation assay for potency testing of betatoxoid containing Clostridium, perfringens type B and type C vaccines for veterinary use.

Ebert E, Kusch M, Öppling V V, Werner E, Cussler K. Ebert E, et al. Among authors: werner e. ALTEX. 1996;13(2):68-75. ALTEX. 1996. PMID: 11178445 English.

10

Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.

Rosskopf-Streicher U, Volkers P, Werner E. Rosskopf-Streicher U, et al. Among authors: werner e. Pharmeuropa Bio. 2004 Jan;2003(2):91-6. Pharmeuropa Bio. 2004. PMID: 14960265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,284 results

Search Page

Filters